Palmer Pamela P 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 8, 2023
Insider Transaction Report
Form 4
Palmer Pamela P
DirectorChief Medical Officer
Transactions
- Tax Payment
Common Stock
2023-02-06$2.02/sh−681$1,376→ 38,777 total
Footnotes (4)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]Balance includes non-reportable acquisition of 500 shares of Common Stock through the Company's Employee Stock Purchase Plan.
- [F4]Reflects a 1-20 reverse stock split which became effective on October 25, 2022.